For RNAi experiments in wing discs, ptc-Gal4 UAS-GFP flies were crossed to UAS-iOfut1 [12.3] flies (S4); progeny were kept at 30°C during larval stages. For marking endosomes, UASrab5:GFP and UAS-rab7:GFP transgenes were used (S8) . As negative controls, ptc-Gal4 UAS-GFP flies were crossed to wild-type flies, and to flies expressing a fold-back construct for a different glycosyltransferase, CG8668 (S9) (Y. Lin and KI, unpublished) .
Two independent insertions of UAS-Ofut1
R245A were isolated , UAS-Ofut1 R245A [20.1] on the second chromosome and UAS-Ofut1 R245A [28.3] on the third chromosome.
Clones of cells mutant for one gene and co-expressing another were generated by the MARCM method (S7, 10, 11) . In brief, this involves repression of the expression of a gene of interest under UAS control by expression of the Gal80 transcriptional repressor. Stocks are designed such that the same mitotic recombination event that generates mutant clones also leads to loss of the Gal80 repressor, allowing expression of the gene of interest (in this case Ofut1 R245A ).
Stocks used for this experiment were y w hs-Flp [122] highly conserved from C. elegans to mammals. In addition, the deletion results in introduction of a stop codon after the first two amino acids (MP), and thus is expected to be a null allele.
Genetically it is more severe than Gmd SH in terms of its influence on wing growth and its stage of lethality.
Cell culture and transfection
For staining and Western blotting experiments, S2 cells were transfected in 24-well tissue culture dishes with 1.6 µg of plasmids using 8 µL Cellfectin (Invitrogen). For AP secretion and ligand binding experiments, transfection was conducted as described previously (S6) . Expression of transgenes under metallothionein control was induced by treatment with with 0.7 mM CuSO 4 for 24h-36h. dsRNA treatment for RNAi experiments was performed as described previously (S4) unless otherwise noted.
Cell and Tissue staining
Antibodies used include mouse anti-aTubulin (DM1A, Sigma), mouse anti-HSP70 (Stressgen), For imaginal disc staining, larva were dissected at late 3rd instar and subjected to immunofluorescent staining as described previously (S17). In situ hybridization was carried out as described previously (S18), using in vitro transcribed Notch (nucleotide 3883-5322) as a probe.
This template was prepared by PCR using the following primers:
T3Notch3883F (T3 sequence is underlined) cells were plated on ConA-treated slides and allowed to spread for 1-2h (S19). Tissue culture slides (8 chamber; Falcon#354118) were treated by coating with 0.5 mg/ml of Con A (from Canavalia ensiformis; Sigma#L7647) for at least 2h.
Western blotting
For the experiment in Figure 2F , S2 cells were lysed in urea-SDS buffer (8 M urea, 5% SDS, 40 mM Tris-HCl pH 6.8, 0.1 mM EDTA and protease inhibitors) (S20) for preparation of total cell lysates. For other experiments, cell lysates were prepared in 1% Triton X-100 buffer (50 mM Hepes pH 7.0, 150 mM NaCl, 1% Triton X-100 and protease inhibitors). Samples were boiled with DTT and applied to 5-15 % gradient SDS-polyacrylamide gels, unless otherwise noted.
Proteins were then transferred to Immobilon-P membrane (Millipore), and stained with primary antibodies as indicated in the figures. For detection, appropriate HRP-conjugated secondary antibodies (1: 50,000 dilution; Amersham Bioscinece) and SuperSignal West Femto Maximum Sensitivity Substrate (PIERCE) were used.
Enzyme activity assays
O-fucosyltransferase activity analysis using an EGF domain from Factor VII was performed as described previously (S4) . For the assay in Fig. S3D . the concentrated culture media containing secreted OFUT1 was used as an enzyme source. For assays with V5-His tagged OFUT1 (Fig.S3B) , OFUT1 was affinity-purified from the culture media using anti-V5 agarose beads (Sigma), and the enzyme-bound beads were used as the enzyme source.
O-fucosyltransferase activity analysis using N:AP as a substrate (Fig. 4E ) was performed as follows: 100 OD/min activity of N:AP or Fc:AP (control) was purified on anti-human placental alkaline phosphatase Ab-conjugated agarose beads (Sigma) and incubated with affinity-purified OFUT1:V5His, Ofut1
R245A
:V5His or the same amount of BSA as a control. To enable detection of small amounts of activity, 0.1 mM of GDP-[14C]fucose was used without dilution with unlabeled GDP-fucose (unlike the assays on Factor VII EGF).
AP secretion assays
To assay the influence of OFUT1 and Fringe on secretion (Figs 5B, S4), pRmHA N:AP, Dl:AP or Ser:AP plasmids (S3) were transfected into S2 cells together with a copia-Renilla plasmid (S21) or pMK33-firefly luciferase as an internal control. For the experiments with RNAi (Fig. 2) , dsRNA for Ofut1 was co-transfected with plasmids so that the ratio between dsRNA and plasmid was 1:2.
After 48h of incubation, protein expression was induce for 48h with CuSO4 as described above.
To quantify the level of secreted AP in the culture media, endogenous AP activity was heatinactivated by incubating at 65°C for 30 min, and AP activity was assayed using 1 mM 4-methylumbelliferyl phosphate (Molecular Probes) as a substrate in 1 M diethanolamine, 1 mM MgCl 2 , at 37°C for 1h and the fluorescent products were measured in a Fusion universal microplate analyzer (Packard). To normalize the transfection activity, sea pansy luciferase or firefly luciferase activity from cell lysates was measured using dual-luciferase reporter assay system (Promega) or steady-glo luciferase assay system (Promega), respectively. Western blotting was also done, and confirmed that amounts of N:AP produced by cells were similar. The culture media were recovered 20 h after induction and centrifuged to removed cell debris. The supernatant was then incubated at room temperature with monoclonal anti-human placental alkaline phosphatase-agarose (8B6; Sigma). After 1h, the beads were pelleted and briefly washed 3 times with HBSS. Protein on the beads was eluted with SDS-loading buffer with DTT and analyzed by Western blotting.
Notch

Ligand binding Assay
Cell-based ligand binding assays were conducted as described previously, with amounts of N:AP or mutant derivates equalized by normalization to AP activity (S3, 6). Equal amounts of protein (4000 mOD/min AP activity) were used in each case. 
Supplemental Figure legends
Figure S5 Model for influence of OFUT1 on Notch folding
